Low-Background Cancer Imaging with a Bioorthogonal Fluorescence Probe and Engineered Reporter Enzyme Bearing a Targeting Moiety
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.5c14173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Ziyi Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Fluorescent Dyes, Glycoside Hydrolases, Optical Imaging. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST-Mirai Program, Toyota Motor Corporation, Daiichi Sankyo Foundation of Life Science.
Abstract (Originalsprache)
Combinatorial use of an antibody-reporter enzyme conjugate and a fluorescence probe activated by the enzyme is a powerful strategy for fluorescence-guided cancer surgery. However, conventional probes for typical reporter enzymes lack sufficient bioorthogonality, leading to high background signals in nontarget tissues. We screened a library of HMRef (rhodol derivative)-based fluorescence probes with various sugar moieties and found that HMRef-β-d-Fucose is bioorthogonal in mammalian systems but is activated by a metagenomic glycosidase, Td2F2. Directed evolution generated a mutant with a kcat/Km of 3.3 × 105/M/sec, 7.3 times higher than wild-type Td2F2 and comparable to β-galactosidase (LacZ) with its corresponding probe. Theoretical calculation suggested the E296G mutation facilitates probe access to the enzyme's active site. In a proof-of-concept study, SKOV-3 cells, which endogenously express HER2, were visualized with minimal background in the mesentery of a mouse model using HMRef-β-d-Fucose and engineered Td2F2 conjugated or fused to a HER2-binding antibody or nanobody.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
- Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
- Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
- Graduate School of Engineering, The University of Tokyo, Tokyo 113-0033, Japan.
- UT7 Next Life Research Group, The University of Tokyo, Tokyo 113-0033, Japan.
- Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, Kanagawa 226-8501, Japan.
ORCID-Profile: Ryosuke Kojima, Kyohhei Fujita, Ryo Tachibana, Yoshihiro Minagawa, Tadahaya Mizuno, Kiyohiko Igarashi, Hiroyuki Noji, Mako Kamiya, Yasuteru Urano
Förderung
- JST-Mirai Program
- Toyota Motor Corporation
- Daiichi Sankyo Foundation of Life Science
- RIKEN
- Precursory Research for Embryonic Science and Technology
- Moonshot Research and Development Program
- Japan Society for the Promotion of Science
- Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
Zitieren
APA
Wang, Z., Kojima, R., Kiji, R., Fujita, K., Tachibana, R., Tsuchiya, R., Uchiyama, T., Minagawa, Y., Mizuno, T., Igarashi, K., Noji, H., Kamiya, M., & Urano, Y. (2026). Low-Background Cancer Imaging with a Bioorthogonal Fluorescence Probe and Engineered Reporter Enzyme Bearing a Targeting Moiety. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c14173
Vancouver
Wang Z, Kojima R, Kiji R, Fujita K, Tachibana R, Tsuchiya R, et al. Low-Background Cancer Imaging with a Bioorthogonal Fluorescence Probe and Engineered Reporter Enzyme Bearing a Targeting Moiety. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.5c14173
BibTeX
@article{Wang2026,
author = {Wang, Ziyi and Kojima, Ryosuke and Kiji, Rikuki and Fujita, Kyohhei and Tachibana, Ryo and Tsuchiya, Reiko and Uchiyama, Taku and Minagawa, Yoshihiro and Mizuno, Tadahaya and Igarashi, Kiyohiko and Noji, Hiroyuki and Kamiya, Mako and Urano, Yasuteru},
title = {Low-Background Cancer Imaging with a Bioorthogonal Fluorescence Probe and Engineered Reporter Enzyme Bearing a Targeting Moiety},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.5c14173}
}
EUVIMED